Lifestyle Natural Medicines
Press release: MHRA reminds healthcare professionals to advise patients of the side effects of GLP-1 agonists and to report misuse
The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding healthcare professionals to ensure patients are aware of the known side effects of glucagon-like peptide-1 (GLP-1) receptor agonists.
These medicines are used to treat type 2 diabetes or obesity, with the common risk of gastrointestinal side effects which may affect more than 1 in 10 patients. While most side effects for these medi… [+5795 chars]
